当前位置:首页 - 行情中心 - 迈克生物(300463) - 财务分析 - 现金流量表

迈克生物

(300463)

  

流通市值:61.92亿  总市值:76.56亿
流通股本:4.95亿   总股本:6.12亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金736,740,132.553,430,504,496.212,649,975,767.781,784,497,111.58
收到的税费返还21,428,623.4192,084,539.5162,206,351.1135,415,253.34
收到其他与经营活动有关的现金7,675,986.9631,082,323.118,890,223.5710,725,730.47
经营活动现金流入的平衡项目0000
经营活动现金流入小计765,844,742.923,553,671,358.822,731,072,342.461,830,638,095.39
购买商品、接受劳务支付的现金438,486,938.761,460,371,506.881,221,017,765.58893,388,705.64
支付给职工以及为职工支付的现金172,434,047.67506,458,379.44395,061,451.43283,988,955.51
支付的各项税费48,756,694.41229,460,157.29168,918,366.14130,548,279.23
支付其他与经营活动有关的现金101,282,774.42455,871,193.22328,954,622.64112,986,900.06
经营活动现金流出的平衡项目0000
经营活动现金流出小计760,960,455.262,652,161,236.832,113,952,205.791,420,912,840.44
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额4,884,287.66901,510,121.99617,120,136.67409,725,254.95
二、投资活动产生的现金流量:
收回投资收到的现金310,000,0002,125,194,226.611,711,000,0001,241,000,000
取得投资收益收到的现金1,961,240.0110,578,413.8112,640,842.389,365,062.21
处置固定资产、无形资产和其他长期资产收回的现金净额5,86018,176,950.166,755,241.864,510,240.86
处置子公司及其他营业单位收到的现金净额---8,687,713.57-
投资活动现金流入的平衡项目0000
投资活动现金流入小计311,967,100.012,153,949,590.581,721,708,370.671,254,875,303.07
购建固定资产、无形资产和其他长期资产支付的现金211,428,278.87877,904,821.86565,236,606.3345,824,228.17
投资支付的现金140,000,0001,770,400,0001,460,150,0001,050,150,000
支付其他与投资活动有关的现金-8,687,713.57--
投资活动现金流出的平衡项目0000
投资活动现金流出小计351,428,278.872,656,992,535.432,025,386,606.31,395,974,228.17
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-39,461,178.86-503,042,944.85-303,678,235.63-141,098,925.1
三、筹资活动产生的现金流量:
取得借款收到的现金134,152,157.14608,746,870.84508,552,525.04498,063,964.89
收到其他与筹资活动有关的现金--300,000-
筹资活动现金流入平衡项目0000
筹资活动现金流入小计134,152,157.14608,746,870.84508,852,525.04498,063,964.89
偿还债务支付的现金86,651,695.17495,020,930.96398,302,284.34267,179,378.6
分配股利、利润或偿付利息支付的现金5,357,192.9247,162,011.4235,091,424.75227,780,871.92
其中:子公司支付给少数股东的股利、利润-2,519,5002,519,5002,074,000
支付其他与筹资活动有关的现金25,977,243.5719,314,510.228,548,043.085,399,725.52
筹资活动现金流出平衡项目0000
筹资活动现金流出小计117,986,131.64761,497,452.58641,941,752.17500,359,976.04
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额16,166,025.5-152,750,581.74-133,089,227.13-2,296,011.15
四、汇率变动对现金及现金等价物的影响167,453.921,352,665.952,347,652.741,413,751.28
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-18,243,411.78247,069,261.35182,700,326.65267,744,069.98
加:期初现金及现金等价物余额811,362,294.43564,293,033.08564,293,033.08564,293,033.08
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额793,118,882.65811,362,294.43746,993,359.73832,037,103.06
补充资料:
净利润-304,679,076.7-171,726,883.6
资产减值准备-94,409,973.72-51,101,774.61
固定资产和投资性房地产折旧-244,555,706.48-115,119,480.89
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-244,555,706.48-115,119,480.89
无形资产摊销-50,384,773.36-17,680,156.48
长期待摊费用摊销-4,739,843.84-1,618,922.57
处置固定资产、无形资产和其他长期资产的损失-4,165,350.13-2,796,308.47
固定资产报废损失-9,543,728.49-3,475,652.03
公允价值变动损失-7,076,745.18-8,702,955.62
财务费用-32,423,042.1-15,467,958.79
投资损失--8,592,386.93--7,904,536.27
递延所得税--34,308,398.91--20,992,292.77
其中:递延所得税资产减少-3,512,476.22--16,792,264.08
递延所得税负债增加--37,820,875.13--4,200,028.69
存货的减少-11,092,073.59--87,015,374.5
经营性应收项目的减少-214,656,871.12-281,814,682.11
经营性应付项目的增加--51,458,427.31--152,076,511.1
现金的期末余额-811,362,294.43-832,037,103.06
减:现金的期初余额-564,293,033.08-564,293,033.08
公告日期2024-04-252024-04-252023-10-262023-07-29
审计意见(境内)标准无保留意见
TOP↑